BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 16481089)

  • 1. The role of the Therapeutic Goods Administration and the Medicine and Medical Devices Safety Authority in evaluating complementary and alternative medicines in Australia and New Zealand.
    Ghosh D; Skinner M; Ferguson LR
    Toxicology; 2006 Apr; 221(1):88-94. PubMed ID: 16481089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The uncritical enthusiasts versus the uninformed sceptics: regulation of complementary and alternative medicines.
    Ellena KR
    J Law Med; 2005 Aug; 13(1):106-24. PubMed ID: 16117160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent legal developments and the authority of the Australian Therapeutic Goods Administration.
    Shirlow E; Faunce T
    J Law Med; 2009 May; 16(5):764-9. PubMed ID: 19554858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australian and New Zealand governments agree to proceed with the joint regulatory agency for therapeutic products.
    Moore J
    J Law Med; 2011 Dec; 19(2):272-4. PubMed ID: 22320002
    [No Abstract]   [Full Text] [Related]  

  • 5. Nutrition labelling: perspectives of a bi-national agency for Australia and New Zealand.
    Curran MA
    Asia Pac J Clin Nutr; 2002; 11(2):S72-6. PubMed ID: 12074190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory issues concerning the safety, efficacy and quality of herbal remedies.
    Rousseaux CG; Schachter H
    Birth Defects Res B Dev Reprod Toxicol; 2003 Dec; 68(6):505-10. PubMed ID: 14745988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regulation of herbal medicines in Australia.
    Briggs DR
    Toxicology; 2002 Dec; 181-182():565-70. PubMed ID: 12505367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The other side of the coin: safety of complementary and alternative medicine.
    Myers SP; Cheras PA
    Med J Aust; 2004 Aug; 181(4):222-5. PubMed ID: 15310261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutrition function, health and related claims on packaged Australian food products--prevalence and compliance with regulations.
    Williams P; Yeatman H; Ridges L; Houston A; Rafferty J; Ridges A; Roesler L; Sobierajski M; Spratt B
    Asia Pac J Clin Nutr; 2006; 15(1):10-20. PubMed ID: 16500873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturopaths practice behaviour: provision and access to information on complementary and alternative medicines.
    Smith C; Martin K; Hotham E; Semple S; Bloustien G; Rao D
    BMC Complement Altern Med; 2005 Jul; 5():15. PubMed ID: 16004617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Access to new medicines in New Zealand compared to Australia.
    Wonder M; Milne R
    N Z Med J; 2011 Nov; 124(1346):12-28. PubMed ID: 22143849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese dragon or toothless tiger? Regulating the professional competence of traditional Chinese medicine practitioners.
    Parker M
    J Law Med; 2003 Feb; 10(3):285-95. PubMed ID: 12650000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of veterinary antibiotics in Australia.
    Dyke TM
    Commun Dis Intell Q Rep; 2003; 27 Suppl():S6-8. PubMed ID: 12807266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developments in health informatics within the standards associations of Australia and New Zealand.
    Neame R
    Stud Health Technol Inform; 1993; 6():25-31. PubMed ID: 10163819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Provision of information on regulatory authorities' websites.
    Vitry A; Lexchin J; Sasich L; Dupin-Spriet T; Reed T; Bertele V; Garattini S; Toop L; Hurley E
    Intern Med J; 2008 Jul; 38(7):559-67. PubMed ID: 18336542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striving for quality use of medicines: how effective is Australia's ban on direct-to-consumer prescription medicine advertising?
    Brown S
    J Law Med; 2009 Feb; 16(4):666-83. PubMed ID: 19297873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cellular therapy in Australia.
    Trickett AE; Wall DM
    Pathology; 2011 Oct; 43(6):627-34. PubMed ID: 21897330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Registration of veterinary drugs in Australia and New Zealand.
    Hotson IK
    J S Afr Vet Assoc; 1981 Jun; 52(2):131-4. PubMed ID: 7196954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory Aspects of Traditional Indian Medicines (TIM) in India and in International Purview.
    Sharma AK; Pundarikakshudu K
    J AOAC Int; 2019 Jul; 102(4):993-1002. PubMed ID: 30609950
    [No Abstract]   [Full Text] [Related]  

  • 20. Complementary medicines advertising policy Part I: unethical conduct in the Australian market before July 2018.
    Vickers M; Harvey K
    Aust Health Rev; 2021 Feb; 45(1):77-83. PubMed ID: 33070836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.